New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
Episode Ep 154 27 min 3s

New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023

Gain insight into expert faculty perspectives as they discuss recent key studies from EHA 2023 on BTK inhibition in chronic lymphocytic leukemia and the potential implications for clinical practice.

You May Also Like

Community discussion